Works by Bridle, Kim R.

Results: 16

Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma.

Published in:

Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00269

By:

Shrestha, Ritu;
Prithviraj, Prashanth;
Anaka, Matthew;
Bridle, Kim R.;
Crawford, Darrell H. G.;
Dhungel, Bijay;
Steel, Jason C.;
Jayachandran, Aparna

Publication type:

Article

Immune checkpoint molecules are regulated by transforming growth factor (TGF)-β1-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.

Published in:

International Journal of Medical Sciences, 2021, v. 18, n. 12, p. 2466, doi. 10.7150/ijms.54239

By:

Shrestha, Ritu;
Bridle, Kim R.;
Crawford, Darrell H. G.;
Jayachandran, Aparna

Publication type:

Article

Two-photon dual imaging platform for in vivo monitoring cellular oxidative stress in liver injury.

Published in:

Scientific Reports, 2017, p. 45374, doi. 10.1038/srep45374

By:

Wang, Haolu;
Zhang, Run;
Bridle, Kim R.;
Jayachandran, Aparna;
Thomas, James A.;
Zhang, Wenzhu;
Yuan, Jingli;
Xu, Zhi Ping;
Crawford, Darrell H. G.;
Liang, Xiaowen;
Liu, Xin;
Roberts, Michael S.

Publication type:

Article

Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox.

Published in:

Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 3, p. 638, doi. 10.1111/jgh.12720

By:

Sobbe, Amy;
Bridle, Kim R;
Jaskowski, Lesley;
Guzman, C Erika;
Santrampurwala, Nishreen;
Clouston, Andrew D;
Campbell, Catherine M;
Subramaniam, V Nathan;
Crawford, Darrell H G

Publication type:

Article

Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3.

Published in:

Journal of Gastroenterology & Hepatology, 2001, v. 16, n. 6, p. 599, doi. 10.1046/j.1440-1746.2001.02445.x

By:

Macdonald,, G;
Macdonald, Graeme A;
Bridle, Kim R;
Ward, Patrick J;
Walker, Neal I;
Houglum, Karl;
George, D Keith;
Smith, Jeffery L;
Powell, Lawrie W;
Crawford, Darrell Hg;
Ramm, Grant A

Publication type:

Article

Lack of efficacy of m TOR inhibitors and ACE pathway inhibitors as antifibrotic agents in evolving and established fibrosis in Mdr2<sup> −/−</sup> mice.

Published in:

Liver International, 2015, v. 35, n. 4, p. 1451, doi. 10.1111/liv.12494

By:

Bridle, Kim R.;
Sobbe, Amy L.;
Guzman, C. Erika;
Santrampurwala, Nishreen;
Jaskowski, Lesley A.;
Clouston, Andrew D.;
Campbell, Catherine M.;
Nathan Subramaniam, V.;
Crawford, Darrell HG

Publication type:

Article

Effect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cells.

Published in:

Liver International, 2007, v. 27, n. 8, p. 1066, doi. 10.1111/j.1478-3231.2007.01573.x

By:

Kobayashi, Yoshimasa;
Bridle, Kim R.;
Ramm, Grant A.;
O'Neill, Rosemary;
Britton, Robert S.;
Bacon, Bruce R.

Publication type:

Article

Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma.

Published in:

International Journal of Cancer, 2020, v. 147, n. 6, p. 1519, doi. 10.1002/ijc.32899

By:

Ruan, Qi;
Wang, Haolu;
Burke, Leslie J.;
Bridle, Kim R.;
Li, Xinxing;
Zhao, Chun‐Xia;
Crawford, Darrell H.G.;
Roberts, Michael S.;
Liang, Xiaowen

Publication type:

Article

TNF-α-mediated epithelial-to-mesenchymal transition regulates expression of immune checkpoint molecules in hepatocellular carcinoma.

Published in:

Molecular Medicine Reports, 2020, v. 21, n. 4, p. 1849, doi. 10.3892/mmr.2020.10991

By:

Shrestha, Ritu;
Bridle, Kim R.;
Crawford, Darrell H.G.;
Jayachandran, Aparna

Publication type:

Article

Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 10, p. 2191, doi. 10.3390/jcm10102191

By:

Cao, Lu;
Prithviraj, Prashanth;
Shrestha, Ritu;
Sharma, Revati;
Anaka, Matthew;
Bridle, Kim R.;
Kannourakis, George;
Crawford, Darrell H.G.;
Jayachandran, Aparna;
Lang, Hauke;
Park, Do Hyun

Publication type:

Article

Combined Inhibition of TGF-β1-Induced EMT and PD-L1 Silencing Re-Sensitizes Hepatocellular Carcinoma to Sorafenib Treatment.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 9, p. 1889, doi. 10.3390/jcm10091889

By:

Shrestha, Ritu;
Prithviraj, Prashanth;
Bridle, Kim R.;
Crawford, Darrell H. G.;
Jayachandran, Aparna;
Andrès, Emmanuel

Publication type:

Article

Inhibition of MLKL Attenuates Necroptotic Cell Death in a Murine Cell Model of Hepatic Ischaemia Injury.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 2, p. 212, doi. 10.3390/jcm10020212

By:

Baidya, Raji;
Gautheron, Jérémie;
Crawford, Darrell H. G.;
Wang, Haolu;
Bridle, Kim R.

Publication type:

Article

Spotlight on Bortezomib: potential in the treatment of hepatocellular carcinoma.

Published in:

Expert Opinion on Investigational Drugs, 2019, v. 28, n. 1, p. 7, doi. 10.1080/13543784.2019.1551359

By:

Huang, I-Tao;
Dhungel, Bijay;
Shrestha, Ritu;
Bridle, Kim R.;
Crawford, Darrell H. G.;
Jayachandran, Aparna;
Steel, Jason C

Publication type:

Article

CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1565, doi. 10.3390/ijms23031565

By:

Cao, Lu;
Bridle, Kim R.;
Shrestha, Ritu;
Prithviraj, Prashanth;
Crawford, Darrell H. G.;
Jayachandran, Aparna

Publication type:

Article

Necroptosis in Hepatosteatotic Ischaemia-Reperfusion Injury.

Published in:

International Journal of Molecular Sciences, 2020, v. 21, n. 16, p. 5931, doi. 10.3390/ijms21165931

By:

Baidya, Raji;
Crawford, Darrell H. G.;
Gautheron, Jérémie;
Wang, Haolu;
Bridle, Kim R.

Publication type:

Article

Dual Targeting of Sorafenib-Resistant HCC-Derived Cancer Stem Cells.

Published in:

Current Oncology, 2021, v. 28, n. 3, p. 2150, doi. 10.3390/curroncol28030200

By:

Shrestha, Ritu;
Bridle, Kim R.;
Lu Cao;
Crawford, Darrell H. G.;
Jayachandran, Aparna

Publication type:

Article